Erythromycin And Benzoyl Peroxide

Gastroparesis, Erythrasma, Whooping Cough + 60 more

Treatment

68 FDA approvals

20 Active Studies for Erythromycin And Benzoyl Peroxide

What is Erythromycin And Benzoyl Peroxide

Erythromycin

The Generic name of this drug

Treatment Summary

Erythromycin is an antibiotic medication that is used to treat a wide variety of bacterial infections. It belongs to a group of antibiotics called macrolides which also includes azithromycin, clarithromycin, and spiramycin. Erythromycin was first discovered in 1952 and can be administered intravenously, topically, or as eye drops.

Erythrocin Stearate

is the brand name

image of different drug pills on a surface

Erythromycin And Benzoyl Peroxide Overview & Background

Brand Name

Generic Name

First FDA Approval

How many FDA approvals?

Erythrocin Stearate

Erythromycin

1964

261

Approved as Treatment by the FDA

Erythromycin, also known as Erythrocin Stearate, is approved by the FDA for 68 uses which include Corynebacterium Infections and Urethritis .

Corynebacterium Infections

Urethritis

Staphylococcus (S.) Aureus Infection

urogenital infections during pregnancy

Pertussis

treponema pallidum infection

Diphtheria

Acne Vulgaris

Used to treat predominant skin comedones, papules and pustules in combination with Tretinoin

penicillins

Bacterial Infections

Communicable Diseases

Conjunctivitis

Respiratory Tract Infections

Erythrasma

Postoperative Infections

Listeriosis

Corynebacterium minutissimum infection

Recurrent Upper and Lower Respiratory Tract Infections (RTIs)

Pneumonia, Mycoplasma

Whooping Cough

Bordetella Pertussis Infection

uncomplicated endocervical infection

Staphylococcal Skin Infections

Communicable Diseases

Acne Vulgaris

Used to treat Acne Vulgaris in combination with Tretinoin

pustular lesions

Used to treat pustular lesions in combination with Avobenzone

Communicable Diseases

Bacterial Infections

Whooping Cough

Pneumonia

Listeria infection

Listeria monocytogenes infection

Acute Otitis Media caused by Haemophilus Influenzae

Used to treat Acute Otitis Media caused by Haemophilus Influenzae in combination with Sulfisoxazole

inflammatory papular lesions

Used to treat inflammatory papular lesions in combination with Avobenzone

Amebiasis

Common Cold

Rheumatic Fever

prophylaxis of Postoperative Infections

Communicable Diseases

prophylaxis of Rheumatic fever

Ureaplasma urethritis

penicillins

Upper Respiratory Tract Infection

Streptococcus Pneumoniae Infections

Streptococcus pyogenes

Staphylococcal Skin Infections

Urethritis

Urinary Tract Infection (UTI)

Legionella pneumophila

Primary Syphilis

Lower Respiratory Tract Infection (LRTI)

Intestinal amebiasis caused by entamoeba histolytica

Skin and skin structure infections

Corynebacterium Infections

diphtheria antitoxin

Bronchitis

Haemophilus Influenzae Infections

Used to treat Haemophilus Influenzae Infections in combination with null

Urethritis

Ureaplasma urealyticum

skin and subcutaneous tissue bacterial infections caused by streptococcus pyogenes

Whooping Cough

Chlamydia Trachomatis

patients with intolerance or contraindications to tetracycline use

Syphilis

First episode of rheumatic fever

Rheumatic Fever

Pneumococcal Infections

Sulfonamides

Effectiveness

How Erythromycin And Benzoyl Peroxide Affects Patients

Erythromycin is an antibiotic used to treat bacterial infections. It works by blocking the bacteria's ability to make proteins, but does not affect nucleic acid synthesis. Depending on the strain of bacteria, erythromycin may be used alone or in combination with a sulfonamide. It is important to test the bacteria for resistance before using erythromycin. Side effects can include pseudomembranous colitis, which can range from mild to serious, and hepatic dysfunction or abnormal liver transaminases, especially if the erythromycin estolate is used.

How Erythromycin And Benzoyl Peroxide works in the body

Erythromycin is a drug that targets bacteria by preventing them from making proteins. It works by attaching to the ribosomal RNA of the bacteria, which is a molecule needed for protein synthesis. By blocking this molecule, erythromycin stops the bacteria from making proteins and in turn, stops them from replicating and spreading. This makes it an effective treatment for various bacterial infections.

When to interrupt dosage

Condition

Dosage

Administration

Amebiasis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Syphilis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Acne Vulgaris

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Chlamydia Trachomatis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Acne Vulgaris

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Granuloma Inguinale

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Whooping Cough

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Communicable Diseases

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Corynebacterium Infections

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Primary Syphilis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

First episode of rheumatic fever

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Legionella pneumophila

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Communicable Diseases

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

patients with intolerance or contraindications to tetracycline use

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Urethritis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Pneumonia, Mycoplasma

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Acute Otitis Media caused by Haemophilus Influenzae

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Gastroparesis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Listeriosis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Urethritis

, 333.0 mg, 20.0 mg/mL, 0.02 mg/mg, 250.0 mg, 0.03 mg/mg, 0.005 mg/mg, 500.0 mg, 400.0 mg, 200.0 mg/mL, 400.0 mg/mL, 0.008 mL/mL, 0.0005 mg/mg, 20.0 mg, 600.0 mg, 1000.0 mg, 0.5 %, 4.0 %, 200.0 mg, 2.0 %, 50.0 mg/mL, 5.0 mg/mL, 15.0 mg/mL, 3.1 mg/mg, 100.0 mg/mL, 3.0 %, 125.0 mg/mL, 25.0 mg/mL, 250.0 mg/mL, 40.0 mg/mL, 0.0012 mg/mg, 0.12 mg/mg

, Kit, Tablet, delayed release - Oral, Oral, Topical, Solution - Topical, Gel, Solution, Gel - Topical, Tablet, film coated, Tablet, film coated - Oral, Capsule, delayed release, Ophthalmic, Ointment - Ophthalmic, Ointment, Tablet, Tablet - Oral, Tablet, delayed release, Suspension, Suspension - Oral, Granule, for suspension, Granule, for suspension - Oral, Capsule, delayed release - Oral, Intravenous, Powder, for solution - Intravenous, Liquid - Oral, Capsule, Capsule - Oral, Lotion - Topical, Lotion; Swab, Lotion; Swab - Topical, Lotion, Injection, powder, lyophilized, for solution, Injection, powder, lyophilized, for solution - Intravenous, Powder, for suspension, Capsule, Delayed Release - Oral, Ointment - Topical, Powder, for solution, Wafer - Oral, Wafer, Kit - Topical, Capsule, coated pellets - Oral, Capsule, delayed release pellets, Capsule, coated pellets, Injection, powder, for solution, Injection, powder, for solution - Intravenous, Swab, Swab - Topical, For suspension, For suspension - Oral, Tablet, coated - Oral, Tablet, coated, Powder, for suspension - Oral, Liquid, Powder, for solution - Oral, Capsule, delayed release pellets - Oral, Powder - Oral, Powder, Capsule, Delayed Release

Warnings

Erythromycin And Benzoyl Peroxide has nine contraindications, so its usage should be avoided if any of the conditions in the following table are present.

Erythromycin And Benzoyl Peroxide Contraindications

Condition

Risk Level

Notes

Severe Hypersensitivity Reactions

Do Not Combine

Erythromycin may interact with Pulse Frequency

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

Pulse Frequency

Do Not Combine

There are 20 known major drug interactions with Erythromycin And Benzoyl Peroxide.

Common Erythromycin And Benzoyl Peroxide Drug Interactions

Drug Name

Risk Level

Description

Abemaciclib

Major

The serum concentration of Abemaciclib can be increased when it is combined with Erythromycin.

Acalabrutinib

Major

The metabolism of Acalabrutinib can be decreased when combined with Erythromycin.

Alectinib

Major

The metabolism of Alectinib can be decreased when combined with Erythromycin.

Alpelisib

Major

The metabolism of Alpelisib can be decreased when combined with Erythromycin.

Aminophylline

Major

The metabolism of Aminophylline can be decreased when combined with Erythromycin.

Erythromycin And Benzoyl Peroxide Toxicity & Overdose Risk

The lowest toxic dose of erythromycin in rats has been found to be 9272mg/kg. If someone overdoses on erythromycin, they may experience diarrhea, nausea, stomach cramps, and vomiting. The drug should be stopped immediately, and the body should try to get rid of any unabsorbed drug. Additional treatments may be needed. Unfortunately, erythromycin cannot be removed from the body through dialysis.

image of a doctor in a lab doing drug, clinical research

Erythromycin And Benzoyl Peroxide Novel Uses: Which Conditions Have a Clinical Trial Featuring Erythromycin And Benzoyl Peroxide?

Condition

Clinical Trials

Trial Phases

Acne Vulgaris

3 Actively Recruiting

Phase 1, Phase 2, Early Phase 1, Phase 4

Listeriosis

0 Actively Recruiting

Legionella pneumophila

0 Actively Recruiting

Urethritis

0 Actively Recruiting

Ureaplasma urealyticum

0 Actively Recruiting

Acute Otitis Media caused by Haemophilus Influenzae

0 Actively Recruiting

Gastroparesis

14 Actively Recruiting

Phase 3, Not Applicable, Phase 1, Early Phase 1

Acne Vulgaris

0 Actively Recruiting

Pneumococcal Infections

0 Actively Recruiting

Corynebacterium minutissimum infection

0 Actively Recruiting

Acne Vulgaris

0 Actively Recruiting

Urinary Tract Infection (UTI)

6 Actively Recruiting

Phase 1, Phase 3, Phase 4, Phase 2

Urethritis

0 Actively Recruiting

Listeria monocytogenes infection

0 Actively Recruiting

Chlamydia Trachomatis

0 Actively Recruiting

Conjunctivitis

0 Actively Recruiting

penicillins

1 Actively Recruiting

Phase 3

Primary Syphilis

0 Actively Recruiting

treponema pallidum infection

0 Actively Recruiting

Communicable Diseases

0 Actively Recruiting

Erythromycin And Benzoyl Peroxide Reviews: What are patients saying about Erythromycin And Benzoyl Peroxide?

5

Patient Review

8/11/2016

Erythromycin And Benzoyl Peroxide for Acne

I had great results with this acne treatment. I only needed to apply a very thin layer and it was more effective than other medications I've tried. I even stopped using it for a while and my skin stayed clear.

5

Patient Review

6/20/2008

Erythromycin And Benzoyl Peroxide for Acne

I had been trying different acne treatments for months to no avail, so I finally saw a doctor. He prescribed this medication, which has worked wonders in just three weeks.

5

Patient Review

5/6/2010

Erythromycin And Benzoyl Peroxide for Acne

I had acne for 17 years and nothing else worked. I'm glad I found this treatment, which has finally helped clear up my skin.

4.3

Patient Review

1/4/2010

Erythromycin And Benzoyl Peroxide for Acne

This ointment is great for treating acne, but it doesn't do anything to prevent it. In fact, I find it so drying that my face becomes super oily within a few hours of using it.

4.3

Patient Review

11/29/2014

Erythromycin And Benzoyl Peroxide for Acne

Though this product did work for me right away, I unfortunately got some in my eyes and they've become severely swollen as a result. Make sure to take the necessary precautions when using this (i.e. keep it away from your eyes) and refrigerate it as directed on the label. I'm going to try a homeopathic remedy like apple cider vinegar with "mother" in it next since I've read that it can be effective against acne with no side effects—unlike this medication (and all medications).

3.7

Patient Review

6/16/2008

Erythromycin And Benzoyl Peroxide for Acne

It took some time to see results, but I'm pleased with how this is working out so far.

3.3

Patient Review

2/8/2021

Erythromycin And Benzoyl Peroxide for Acne

This treatment helped my acne when nothing else did. However, I experienced a chemical burn around my mouth, chin, and under eyes (I was careful to avoid those areas). The burn caused lines and wrinkles that I now have to get treated for. It's unpleasant and I would caution others before using this product.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about erythromycin and benzoyl peroxide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do you wash off erythromycin and benzoyl peroxide topical gel?

"In that case, you may want to wash your face more often.

If your skin is freshly washed or shaved, the alcohol in the mixed medicine may irritate it. Try to avoid washing the acne-affected area(s) too often, as this can dry out your skin and make your acne worse. Washing your face with a mild, bland soap 2 or 3 times a day should be enough, unless you have oily skin. If that's the case, you may need to wash your face more often."

Answered by AI

How long does it take for erythromycin and benzoyl peroxide topical gel to work?

"After using this product for a few weeks, acne should improve. However, it may take a couple of months to see the full benefits of using this product."

Answered by AI

Can I use benzoyl peroxide with erythromycin?

"This medicine is a combination of erythromycin and benzoyl peroxide and is used to treat acne. Erythromycin works by killing the bacteria that cause acne, and benzoyl peroxide works by keeping the skin pores clean. This medicine is available only with your doctor's prescription."

Answered by AI

Which is better erythromycin or benzoyl peroxide?

"Erythromycin lotion and benzoyl peroxide gel are both effective in reducing the number of small inflamed lesions and overall acne severity, according to a double-blind clinical study."

Answered by AI

Clinical Trials for Erythromycin And Benzoyl Peroxide

Image of Children's Healthcare of Atlanta in Atlanta, United States.

Antibiotic Strategies for Pneumonia in Children

12 - 71
All Sexes
Atlanta, GA

The goal of this clinical trial is to determine if a "watch and wait" antibiotic strategy, called Safety Net Antibiotic Prescribing (SNAP), can safely reduce unnecessary antibiotic use while ensuring that children diagnosed with community-acquired pneumonia get better from their illness. The main aims of this study are: * To compare the effectiveness of SNAP versus immediate antibiotic prescribing in children with mild community-acquired pneumonia (CAP) * To identify which patient groups benefit most from the SNAP strategy * To identify factors that shape implementation of each prescribing strategy. Researchers will compare the SNAP strategy (where parents or guardians are instructed to give antibiotics only if their child is not improving after 72 hours, or sooner if they are worsening) to the immediate antibiotic prescribing strategy (where parents or guardians are instructed to give the antibiotics right after their healthcare visit) to see if one strategy is more effective than the other. Participants will be randomly assigned to either the immediate antibiotic group or the SNAP group at enrollment. Participation lasts 14 days with follow-up surveys at 4, 7, and 14 days after enrollment.

Recruiting
Has No Placebo

Children's Healthcare of Atlanta (+3 Sites)

Todd Florin, MD, MSCE

Have you considered Erythromycin And Benzoyl Peroxide clinical trials?

We made a collection of clinical trials featuring Erythromycin And Benzoyl Peroxide, we think they might fit your search criteria.
Go to Trials
Image of Children's Community Pediatrics Brentwood in Pittsburgh, United States.

AI Diagnostic Support for Ear Infections

6 - 24
All Sexes
Pittsburgh, PA

Ear infections are common in young children with cold symptoms, but they can be difficult to diagnose due to small ear canals, child movement, and limited viewing time. In this study, investigators will take photos of the eardrums of children 6-24 months of age with upper respiratory symptoms. The photos will be reviewed by imaging software enhanced with artificial intelligence (AI app) to determine whether the AI app changes how ear infections are diagnosed and treated. The AI app has undergone rigorous study and was found to be highly accurate; but how using this technology affects the diagnosis and treatment by clinicians has not been studied. This research may help improve diagnostic accuracy for ear infections and ensure antibiotics are prescribed only for those children who have definite ear infections.

Recruiting
Has No Placebo

Children's Community Pediatrics Brentwood (+1 Sites)

Timothy R Shope, MD, MPH

Merck Sharp & Dohme LLC

Image of Maternity Centre of Hamilton in Hamilton, Canada.

Rapid Test for Syphilis

13 - 49
All Sexes
Hamilton, Canada

The goal of this clinical trial is to learn if a finger-prick blood test for rapid diagnosis of syphilis infection can be implemented in a low-barrier prenatal clinic for people at risk of syphilis in pregnancy. The test gives results in 5 minutes and also tests for HIV. The main questions the study aims to answer are: * How often do pregnant people at risk of syphilis agree to the rapid test? * How well do healthcare providers perform the rapid test? * Does the rapid test speed up diagnosis and treatment of syphilis in pregnant people and their sexual partners? Participants will: * Give feedback about why they did or did not want to take the rapid test, and what their experience was taking the test; and * Share information about their health, pregnancy, and syphilis treatment (if applicable).

Recruiting
Has No Placebo

Maternity Centre of Hamilton

Laura K Erdman, MD PhD FRCPC

Image of Benioff Children's Hospital - Oakland in Oakland, United States.

Decision Support for Lower Respiratory Infections in Children

6 - 17
All Sexes
Oakland, CA

Eliminating inappropriate antibiotic use in pediatric lower respiratory tract infections (LRTI) is the central focus of this research. LRTIs (pneumonia, bronchiolitis, and infection-related exacerbations of asthma) account for nearly one-third of all emergency department (ED) visits and 40% of all infection-related hospitalizations in US children. LRTIs also account for more antibiotic use in children's hospitals than any other condition, despite most LRTIs being viral in nature. Inappropriate antibiotics are associated with substantial adverse effects. Accordingly, national guidelines strongly discourage routine antibiotic use for bronchiolitis and acute asthma and argue for significantly reducing antibiotic exposure (initiation, spectrum, and duration) in pneumonia. To address the problem of inappropriate antibiotic use, hospital-based antimicrobial stewardship programs (ASPs) are now common nationwide, and these programs have demonstrated effectiveness in some hospital settings. Unfortunately, traditional ASP approaches do not translate well to the fast-paced and unpredictable ED environment, and hospital-based ASP resources are finite and not always immediately available. Clinical decision support (CDS) embedded within the electronic health record (EHR) is a strategy that could address the ED antibiotic stewardship gap. Informed by a deep understanding of the key facilitators and barriers to using CDS to support appropriate antibiotic use in ED and hospital settings, the investigators have developed two stewardship-focused CDS interventions for pediatric LRTI. The overarching goal of this research is to rigorously evaluate the implementation and effectiveness of these CDS tools, alone and in combination, against usual care only in a pragmatic randomized clinical trial at 3 U.S. children's hospitals.

Recruiting
Has No Placebo

Benioff Children's Hospital - Oakland (+2 Sites)

Derek J Williams, MD, MPH

Have you considered Erythromycin And Benzoyl Peroxide clinical trials?

We made a collection of clinical trials featuring Erythromycin And Benzoyl Peroxide, we think they might fit your search criteria.
Go to Trials
Image of University of Pennsylvania Primary Care Practice in Philadelphia, United States.

Rapid Testing for Upper Respiratory Tract Infection

18+
All Sexes
Philadelphia, PA

The goal of this study is to understand the use of point of care (POC) testing devices in primary care offices to help clinicians diagnose and appropriately treat patients who have symptoms of upper respiratory infections (URIs). The study will use the BIOFIRE® SPOTFIRE® Respiratory (R) Panel testing device, which is FDA-cleared and CLIA-Waived. This panel can identify up to 15 different viruses and bacteria that can cause URIs. These POC devices will be installed in primary care clinics within the University of Pennsylvania Health System. Patients who come to the clinic with cold-like symptoms (runny nose, cough) will be offered the test. If the patient agrees to the test, their clinician will use a swab to take a small sample of fluid from their nose. This swab will then be tested within the POC device and results will be available within 15 minutes. The results of this sample will be shared with the patient, and their clinician can use the results to help decide the most appropriate medical treatment for the patient. Patients who agree to take the test will be asked to answer a short survey about the test and their experience. Clinicians will also be surveyed to share their thoughts with using the test in their clinics. Focus groups of practice staff and clinicians will also be conducted to understand any potential challenges for using this test in practice. Results from the tests and the surveys will help researchers understand the value of the test to support antibiotic stewardship efforts in primary care clinic settings.

Waitlist Available
Has No Placebo

University of Pennsylvania Primary Care Practice

Have you considered Erythromycin And Benzoyl Peroxide clinical trials?

We made a collection of clinical trials featuring Erythromycin And Benzoyl Peroxide, we think they might fit your search criteria.
Go to Trials